We can help you get approved medicine that isn't approved or available in your home country.. To learn more, fill out the form below.
YERVOY @ is a human cytotoxic T-lymphocyte antigen 4 (CTLA-4)-blocking antibody indicated for:
Treatment: of unresectable or metastatic melanoma in adults and pediatric patients (12 years and older)
Adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more than 1 mm who have undergone complete resection, including total lymphadenectomy
Treatment of patients with intermediate or poor risk, previously untreated advanced renal cell carcinoma, in combination with nivolumab
The information provided herein is not medical advice and is not intend to replace medical advice offered by a health care provider. Please consult your health care provider for advice.